Start Point Advisors

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 11, 2021	China Immunotech	$31.0M Series B	China Growth Capital	Beijing Changping Science Park Development, Fenghai Capital, Guangzhou Sanheyue, Sangel Capital, Jianwei YUAN

Total Raised

N/A

Valuation

N/A